-

SHAREHOLDER ALERT: Robbins LLP Investigates Natera, Inc. (NTRA) on Behalf of Shareholders

SAN DIEGO--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP is investigating Natera, Inc. (NASDAQ: NTRA) to determine whether certain Natera officers and directors violated securities laws and breached fiduciary duties to shareholders. Natera develops and commercializes molecular testing, including a non-invasive prenatal test that screens for chromosomal abnormalities.

If you would like more information about our investigation of Natera, Inc.'s misconduct, click here.

Natera, Inc.'s (NTRA) Prenatal Tests May be Inaccurate

On January 1, 2022, an article from the New York Times called into question the accuracy of certain noninvasive prenatal tests, including that developed by Natera. The article alleges that positive results on tests are incorrect about 85% percent of the time. Patients who receive a positive result are supposed to pursue follow-up testing, which are expensive, invasive and cannot be performed until later in pregnancy. The investigation highlights the statistical challenge of testing from things that are extremely rare. But, this isn't adequately explained to patients who were sold the tests. Companies that develop these tests use language like "highly accurate" and "total confidence," do not publish data on their tests' overall performance, or only stress data from tests that are more accurate.

On this news, Natera's stock declined as much as 3.5% during intraday trading on January 3, 2022, injuring investors.

Natera, Inc. (NTRA) shareholders have legal options. If you own shares of Natera, Inc. contact us for more information about your legal options.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

Contact us to learn more:

Aaron Dumas
(800) 350-6003
adumas@robbinsllp.com
Shareholder Information Form

About Robbins LLP: A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance structures, and hold company executives accountable for their wrongdoing since 2002. To be notified if a class action against Natera, Inc. settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Aaron Dumas
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

More News From Robbins LLP

Stockholder Alert: Robbins LLP Informs Investors of the Fractyl Health, Inc. Class Action

SAN DIEGO--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP informs investors that a class action was filed on behalf of all persons and entities who purchased or otherwise acquired Fractyl Health, Inc. (NASDAQ: GUTS) securities between January 13, 2025 and January 29, 2026 (the "Class Period"). Fractyl is a metabolic therapeutics company that develops therapies for the treatment of type 2 diabetes (“T2D”) and obesity.The complaint alleges that Fractyl Health misled investors regarding t...

Stockholder Alert: Robbins LLP Informs Investors of the GoDaddy Inc. Class Action

SAN DIEGO--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP informs investors that a class action was filed on behalf of all persons and entities who purchased or otherwise acquired GoDaddy Inc. (NYSE: GDDY) common stock between September 3, 2025 and February 24, 2026 (the "Class Period"). GoDaddy is an internet domain registry, domain registrar, and web hosting company headquartered in Tempe, Arizona.The complaint alleges that GoDaddy failed to disclose to investors that it had initiate...

Stockholder Alert: Robbins LLP Informs Investors of the AEVEX Corp. Class Action

SAN DIEGO--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP informs investors that a class action was filed on behalf of all persons and entities who purchased or otherwise acquired AEVEX Corp. (NYSE: AVEX) Class A common stock (a) between April 17, 2026 and June 4, 2026, and (b) pursuant to the Company's initial public offering ("IPO") on April 17, 2026 (the "Class Period"). AEVEX is a military technology contractor.The complaint alleges that AEVEX concealed a pre-arranged plan between...
Back to Newsroom